Search Through All Notices
Joint Information Center – JIC Release No. 1047
May 11, 2022, 5:55 p.m. (ChST)
COVID-19 Test Results: 30 New Cases, Four Hospitalized;
10 Cases with Variants of Concern Identified; Second COVID-19 Booster Doses Available
COVID-19 Test Results: 30 New Cases Reported
Today, the Department of Public Health and Social Services (DPHSS) reported 30 new cases of COVID-19 from 712specimens analyzed May 10, 2022. 13 of the cases reported today are through the Department of Defense. To date, there have been a total of 48,431 officially reported cases, 358 deaths, 195 cases in active isolation, and 47,878 not in active isolation.
Four Hospitalized for COVID-19
SPECIAL NOTE: Based on today's data, if we were to compare two (2) hypothetical populations of 100,000 people each, vaccinated versus unvaccinated, there would be 2 vaccinated people hospitalized for COVID-19 compared to 20 unvaccinated people hospitalized for COVID-19. The risk of being hospitalized for COVID-19 is about 10 times higher for the unvaccinated as compared to the vaccinated. *Estimated population is based on DPHSS Immunization Program analysis of 2020 Census data. Updates are expected pending further Census 2020 data breakdown.
10 Cases with Variants of Concern Identified
Today, DPHSS received ten (10) new results from virus samples collected on Guam between April 1 to April 6, 2022, which have undergone genome sequencing by the Hawaii Department of Health (DOH) State Laboratory Division. DPHSS received the eighth set of results from the Hawaii DOH State Laboratory Division. All 10 samples were identified as the Omicron Variant of Concern (VOC). The breakdown is as follows:
Omicron
· Nine (9) BA.2.3
· One (1) BA.2
To date, 756 SARS-CoV-2 virus samples have been submitted to the U.S. Centers for Disease Control and Prevention (CDC) and the Hawaii DOH State Lab Division for genome sequencing.
Second COVID-19 Booster Doses Available
Second doses of the COVID-19 booster are available to individuals ages 12 years and older who are moderately or severely immunocompromised. Eligible individuals may choose to receive a second booster dose using an mRNA (Pfizer-BioNTech or Moderna) COVID-19 vaccine at least 4 months after the first booster dose.
Additionally, adults between the ages of 18 and 49 who are not moderately or severely immunocompromised and who received Janssen COVID-19 Vaccine as both their primary series dose and booster dose may receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the Janssen booster dose. Adults ages 50 years and older could benefit from a second mRNA booster dose as they are at increased risk for severe COVID-19. Adults 50 years and older may choose to receive a second booster dose, if it has been at least 4 months after the first booster dose.
Guam COVID-19 Vaccination Update
As of May 10, 2022, 136,505 eligible residents (5 years and older) are fully vaccinated. This total includes 13,974residents 12 – 17 years old. 7,982 residents 5 – 11 years old received their first dose of the Pfizer-BioNTech two dose series. 6,376 residents 5 – 11 years old have completed their two-dose series. 58,848 eligible residents have received their first booster shots. 3,998 eligible residents have received their second booster shots.
-###-
May 11, 2022, 5:55 p.m. (ChST)
COVID-19 Test Results: 30 New Cases, Four Hospitalized;
10 Cases with Variants of Concern Identified; Second COVID-19 Booster Doses Available
COVID-19 Test Results: 30 New Cases Reported
Today, the Department of Public Health and Social Services (DPHSS) reported 30 new cases of COVID-19 from 712specimens analyzed May 10, 2022. 13 of the cases reported today are through the Department of Defense. To date, there have been a total of 48,431 officially reported cases, 358 deaths, 195 cases in active isolation, and 47,878 not in active isolation.
Four Hospitalized for COVID-19
| CENSUS as of 5 p.m. | GMH | GRMC | USNH | TOTAL |
|---|---|---|---|---|
| COVID-19 Admission | 2 | 1 | 1 | 4 |
| Pediatric Admissions | 0 | - | - | 0 |
| ICU | 1 | 0 | 0 | 1 |
| Ventilator | 0 | 0 | 0 | 0 |
| VACCINATION STATUS | VACCINATED | UNVACCINATED | INELIGIBLE (0-4 years old) |
| Hospitalized | 3 | 1 | 0 |
| Total in Population* | 136,505 | 5,102 | 12,229 |
| Rate per 100,000 Population | 2 | 20 | 0 |
10 Cases with Variants of Concern Identified
Today, DPHSS received ten (10) new results from virus samples collected on Guam between April 1 to April 6, 2022, which have undergone genome sequencing by the Hawaii Department of Health (DOH) State Laboratory Division. DPHSS received the eighth set of results from the Hawaii DOH State Laboratory Division. All 10 samples were identified as the Omicron Variant of Concern (VOC). The breakdown is as follows:
Omicron
· Nine (9) BA.2.3
· One (1) BA.2
To date, 756 SARS-CoV-2 virus samples have been submitted to the U.S. Centers for Disease Control and Prevention (CDC) and the Hawaii DOH State Lab Division for genome sequencing.
Second COVID-19 Booster Doses Available
Second doses of the COVID-19 booster are available to individuals ages 12 years and older who are moderately or severely immunocompromised. Eligible individuals may choose to receive a second booster dose using an mRNA (Pfizer-BioNTech or Moderna) COVID-19 vaccine at least 4 months after the first booster dose.
Additionally, adults between the ages of 18 and 49 who are not moderately or severely immunocompromised and who received Janssen COVID-19 Vaccine as both their primary series dose and booster dose may receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the Janssen booster dose. Adults ages 50 years and older could benefit from a second mRNA booster dose as they are at increased risk for severe COVID-19. Adults 50 years and older may choose to receive a second booster dose, if it has been at least 4 months after the first booster dose.
|
FREE COVID-19 VACCINATION CLINICS (AGES 5 AND OVER) FIRST, SECOND AND BOOSTER SHOTS AVAILABLE - Pfizer-BioNTech, Moderna, Johnson & Johnson |
|
|
Mon. - Sat. 11 a.m. - 5 p.m. |
Agana Shopping Center (2nd Floor) - Register: tinyurl.com/vaxguam Walk-ins are welcome, but appointments will be expedited. Bring appointment confirmation and proof of identity. Last appointment is 30 minutes before closing. |
|
Mon. - Thurs. 9 a.m. - 5 p.m. Sat: 9 a.m. - 12 p.m. |
DPHSS Northern Region Community Health Center (NRCHC), Dededo Call 671-635-4418/7400 to schedule an appointment. Last appointment is 30 minutes before closing. Walk-ins welcome. Curbside vaccination available for people with disabilities. Register at tinyurl.com/covidstopswithme |
|
Mon. - Sat. 9 a.m. - 12 p.m. |
DPHSS Southern Region Community Health Center (SRCHC), Inalåhan Call (671) 828-7604/5/7518 to schedule an appointment. Last appointment is 30 minutes before closing. Walk-ins welcome. Curbside vaccination available for people with disabilities. Register at tinyurl.com/covidstopswithme |
|
FREE COVID-19 COMMUNITY TESTING Fill out a COVID-19 Testing Patient Assessment Form ahead of time, available at dphss.guam.gov/covid-19-testing. |
|
|
Mon, Wed, Fri, & Sat: 8 a.m. - 11 a.m. |
Old Carnival Grounds, Tiyan, Barrigada COVID-19 testing will be offered by appointment through tinyurl.com/covidstopswithme. Four adults per vehicle. Bring a photo ID.Travel-related testing will not be offered. NO SYMPTOMS NEEDED TO TEST FOR COVID-19 |
|
Tuesdays and Thursdays: 9 a.m. - 12 p.m. |
DPHSS Southern Region Community Health Center (SRCHC), Inalåhan By appointment only for individuals with COVID-like symptoms. Four adults per vehicle. Bring a photo ID. Travel-related testing not offered. Call (671) 828-7604/5/7518. Register at tinyurl.com/covidstopswithme |
|
Monday through Saturday: 9 a.m. - 12 p.m. |
DPHSS Northern Region Community Health Center (NRCHC), Dededo By appointment only for individuals with COVID-like symptoms. Four adults per vehicle. Bring a photo ID. Call (671) 635-7525/6 to schedule an appointment. |
Guam COVID-19 Vaccination Update
As of May 10, 2022, 136,505 eligible residents (5 years and older) are fully vaccinated. This total includes 13,974residents 12 – 17 years old. 7,982 residents 5 – 11 years old received their first dose of the Pfizer-BioNTech two dose series. 6,376 residents 5 – 11 years old have completed their two-dose series. 58,848 eligible residents have received their first booster shots. 3,998 eligible residents have received their second booster shots.
-###-
